CURAXIS PHARMACEUTICAL Corp - FORM 8-K - EX-17.5 - RESIGNATION LETTER OF RONALD POMPEO - June 30, 2011

Attached files

file filename
8-K - CURRENT REPORT - CURAXIS PHARMACEUTICAL Corpasch_8k.htm
EX-17.1 - RESIGNATION LETTER OF PATRICK SMITH - CURAXIS PHARMACEUTICAL Corpasch_ex171.htm
EX-17.2 - RESIGNATION LETTER OF DAVID CORCORAN - CURAXIS PHARMACEUTICAL Corpasch_ex172.htm
EX-17.3 - RESIGNATION LETTER OF SHELDON GOLDBERG - CURAXIS PHARMACEUTICAL Corpasch_ex173.htm
EX-99.1 - PRESS RELEASE - CURAXIS PHARMACEUTICAL Corpasch_ex991.htm
EX-3.1 - SECOND AMENDED AND RESTATED BYLAWS - CURAXIS PHARMACEUTICAL Corpasch_ex31.htm
EX-17.4 - RESIGNATION LETTER OF WILLIAM MCCONVILLE - CURAXIS PHARMACEUTICAL Corpasch_ex174.htm
 
Exhibit 17.5
 
 
June 24, 2011
 
Curaxis Pharmaceutical, Corp.
51 Berkshire Street
Swampscott, MA 01907


Gentlemen:
 
This letter confirms that I, Ronald V. Pompeo, hereby resign from my position as a director of Curaxis Pharmaceutical, Corp. (the “Company”) effective immediately.  My resignation is not the result of any disagreement with the Company on any matter relating to its operations, policies (including accounting or financial policies) or practices.
 
Sincerely,
 

 
 
/s/Ronald V. Pompeo  
Ronald V. Pompeo
  
 
 

CURAXIS PHARMACEUTICAL Corp Reports